Long-term Health-related Quality of Life in Patients Treated With Subcutaneous C1-Inhibitor Replacement Therapy for the Prevention of Hereditary Angioedema Attacks

被引：0

作者：

Lumry, William R. ^{[1
]}

Craig, Timothy J. ^{[2
]}

Magerl, Markus A. K. ^{[3
]}

Farkas, Henriette ^{[4
]}

Lawo, John-Philip ^{[5
]}

Chiao, Joseph ^{[6
]}

Machnig, Thomas ^{[5
]}

机构：

[1] AARA Res Ctr, Dallas, TX USA

[2] Penn State Coll Med, Hershey, PA USA

[3] Charite, Dept Dermatol & Allergy, Berlin, Germany

[4] Semmelweis Univ, Hungarian Angioedema Reference Ctr, Dept Internal Med 3, Budapest, Hungary

[5] CSL Behring GmbH, Marburg, Germany

[6] CSL Behring, King Of Prussia, PA USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2019年 / 143卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

113

引用

页码：AB39 / AB39

页数：1

共 50 条

[1] Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema
Lumry, William R.
Craig, Timothy
Zuraw, Bruce
Longhurst, Hilary
Baker, James
Li, H. Henry
Bernstein, Jonathan A.
Anderson, John
Riedl, Marc A.
Manning, Michael E.
Keith, Paul K.
Levy, Donald S.
Caballero, Teresa
Banerji, Aleena
Gower, Richard G.
Farkas, Henriette
Lawo, John-Philip
Pragst, Ingo
Machnig, Thomas
Watson, Douglas J.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (05): : 1733 - +
[2] Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks
Craig, Timothy
Zuraw, Bruce
Longhurst, Hilary
Cicardi, Marco
Bork, Konrad
Grattan, Clive
Katelaris, Constance
Sussman, Gordon
Keith, Paul K.
Yang, William
Hebert, Jacques
Hanzlikova, Jana
Staubach-Renz, Petra
Martinez-Saguer, Inmaculada
Magerl, Markus
Aygoren-Pursun, Emel
Farkas, Henriette
Reshef, Avner
Kivity, Shmuel
Neri, Sergio
Crisan, Ioana
Caballero, Teresa
Baeza, Maria L.
Dolores Hernandez, Maria
Li, Henry
Lumry, William
Bernstein, Jonathan A.
Hussain, Iftikar
Anderson, John
Schwartz, Lawrence B.
Jacobs, Joshua
Manning, Michael
Levy, Donald
Riedl, Marc
Christiansen, Sandra
Feuersenger, Henrike
Pragst, Ingo
Mycroft, Sarah
Pawaskar, Dipti
Jacobs, Iris
Zuraw, Bruce L.
Cicardi, Marco
Craig, Timothy
Longhurst, Hilary
Grattan, Clive
Grattan, Clive
Bork, Konrad
Kreuz, Wolfhart
Jacobs, Iris
Pragst, Ingo
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (06): : 1793 - +
[3] Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study
William R. Lumry
Bruce Zuraw
Marco Cicardi
Timothy Craig
John Anderson
Aleena Banerji
Jonathan A. Bernstein
Teresa Caballero
Henriette Farkas
Richard G. Gower
Paul K. Keith
Donald S. Levy
H. Henry Li
Markus Magerl
Michael Manning
Marc A. Riedl
John-Philip Lawo
Subhransu Prusty
Thomas Machnig
Hilary Longhurst
[J]. Orphanet Journal of Rare Diseases, 16
[4] Advances in Hereditary Angioedema: The Prevention of Angioedema Attacks With Subcutaneous C1-Inhibitor Replacement Therapy
Lumry, William
Templeton, Teri
Omert, Laurel
Levy, Donald
[J]. JOURNAL OF INFUSION NURSING, 2020, 43 (03) : 134 - 145
[5] Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (vol 16, 86, 2021)
Lumry, William R.
Zuraw, Bruce
Cicardi, Marco
Craig, Timothy
Anderson, John
Banerji, Aleena
Bernstein, Jonathan A.
Caballero, Teresa
Farkas, Henriette
Gower, Richard G.
Keith, Paul K.
Levy, Donald S.
Li, H. Henry
Magerl, Markus
Manning, Michael
Riedl, Marc A.
Lawo, John-Philip
Prusty, Subhransu
Machnig, Thomas
Longhurst, Hilary
[J]. ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
[6] C1-inhibitor therapy for hereditary angioedema attacks: Prospective patient assessments of health-related quality of life
Bewtra, Againdra K.
Levy, Robyn J.
Jacobson, Kraig W.
Wasserman, Richard L.
Machnig, Thomas
Craig, Timothy J.
[J]. ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (05) : 427 - 431
[7] Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase
Weller, Karsten
Maurer, Marcus
Fridman, Moshe
Supina, Dylan
Schranz, Jennifer
Magerl, Markus
[J]. ALLERGY AND ASTHMA PROCEEDINGS, 2017, 38 (02) : 143 - 151
[8] LONG-TERM PROPHYLAXIS WITH SUBCUTANEOUS C1-INHIBITOR IN US PATIENTS WITH HEREDITARY ANGIOEDEMA AND VERY FREQUENT ATTACKS
Craig, T.
Zuraw, B.
Cicardi, M.
Longhurst, H.
Feuersenger, H.
Prusty, S.
Jacobs, I.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S31 - S31
[9] Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema
Pawaskar, Dipti
Tortorici, Michael A.
Zuraw, Bruce
Craig, Timothy
Cicardi, Marco
Longhurst, Hilary
Li, H. Henry
Lumry, William R.
Martinez-Saguer, Inmaculada
Jacobs, Joshua
Bernstein, Jonathan A.
Riedl, Marc A.
Katelaris, Constance H.
Keith, Paul K.
Feussner, Annette
Sidhu, Jagdev
[J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (10): : 1325 - 1332
[10] A RANDOMIZED TRIAL OF SUBCUTANEOUS C1-INHIBITOR FOR THE PREVENTION OF HEREDITARY ANGIOEDEMA ATTACKS
Zuraw, B.
Craig, T.
Cicardi, M.
Longhurst, H.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S1 - S1

← 1 2 3 4 5 →